Event Date/Time: Jun 08, 2011
Many stakeholders have recently raised concerns with the usefulness of the current static Product Information which has been nearly unchanged for several decades. The new Pharmacovigilance Legislation is now tasking the European Commission to provide a report on the current product information and its usefulness to stakeholders. This Product Information Forum is trying to identify challenges and opportunities for developing a new vision that may better meet various stakeholder needs. It will highlight the labelling development process within pharmaceutical companies and stress some legal aspects. Learning's from national initiatives that may be useful for a European approach will be discussed. In today's Internet world, the use of new media and smart design may also provide additional value to this important Medical communication tool.